Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Safety and Efficacy of ANG-3070 in Patients With Primary Glomerular Disease and Persistent Proteinuria

NCT04939116 is registered in ClinicalTrials.gov with Angion Biomedica Corp as lead sponsor.

NCT NCT04939116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04939116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Safety and Efficacy of ANG-3070 in Patients With Primary Glomerular Disease and Persistent Proteinuria
Lead sponsor
Angion Biomedica Corp
Phase
Phase 2
Overall status
Unknown status
Start date
December 24, 2021
Completion date
August 31, 2023
Enrollment
100 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

glomerular disease, proteinuria